if you want a good drug for traumatic brain injury (TBI) - have a look at NEU
their Glypromate is in advanced clinical trials
That's the problem with phylogica imo - they only have potential compounds in pre-clinical - there is little value and little incentive for licensing without proof of concept
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.25 |
Change
-0.010(0.79%) |
Mkt cap ! $705.7M | |||
| Open | High | Low | Value | Volume |
| $1.25 | $1.26 | $1.19 | $307.8K | 252.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 9313 | $1.23 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.26 | 8075 | 4 |
View Market Depth
| Last trade - 12.13pm 29/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |